The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

C13 Stable Isotope Labeled Biomolecules-Global Market Insights and Sales Trends 2024

C13 Stable Isotope Labeled Biomolecules-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1840885

No of Pages : 103

Ask Your Query
Synopsis
The global C13 Stable Isotope Labeled Biomolecules market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of C13 Stable Isotope Labeled Biomolecules in various end use industries. The expanding demands from the Scientific Research, Medical, Industrial and Others, are propelling C13 Stable Isotope Labeled Biomolecules market. Medical C13 Stable Isotope Labeled Biomolecules, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for C13 Stable Isotope Labeled Biomolecules market, driven by demand from China, the second largest economy with some signs of stabilising, the C13 Stable Isotope Labeled Biomolecules market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for C13 Stable Isotope Labeled Biomolecules, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global C13 Stable Isotope Labeled Biomolecules market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global C13 Stable Isotope Labeled Biomolecules market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, C13 Stable Isotope Labeled Biomolecules sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of C13 Stable Isotope Labeled Biomolecules covered in this report include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes, etc.
The global C13 Stable Isotope Labeled Biomolecules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Global C13 Stable Isotope Labeled Biomolecules market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global C13 Stable Isotope Labeled Biomolecules market, Segment by Type:
Medical C13 Stable Isotope Labeled Biomolecules
Others
Global C13 Stable Isotope Labeled Biomolecules market, by Application
Scientific Research
Medical
Industrial
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of C13 Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 C13 Stable Isotope Labeled Biomolecules Market Overview
1.1 C13 Stable Isotope Labeled Biomolecules Product Overview
1.2 C13 Stable Isotope Labeled Biomolecules Market Segment by Type
1.2.1 Medical C13 Stable Isotope Labeled Biomolecules
1.2.2 Others
1.3 Global C13 Stable Isotope Labeled Biomolecules Market Size by Type
1.3.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Overview by Type (2018-2029)
1.3.2 Global C13 Stable Isotope Labeled Biomolecules Historic Market Size Review by Type (2018-2023)
1.3.3 Global C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Type (2018-2023)
1.4.2 Europe C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Type (2018-2023)
1.4.4 Latin America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Type (2018-2023)
2 Global C13 Stable Isotope Labeled Biomolecules Market Competition by Company
2.1 Global Top Players by C13 Stable Isotope Labeled Biomolecules Sales (2018-2023)
2.2 Global Top Players by C13 Stable Isotope Labeled Biomolecules Revenue (2018-2023)
2.3 Global Top Players by C13 Stable Isotope Labeled Biomolecules Price (2018-2023)
2.4 Global Top Manufacturers C13 Stable Isotope Labeled Biomolecules Manufacturing Base Distribution, Sales Area, Product Type
2.5 C13 Stable Isotope Labeled Biomolecules Market Competitive Situation and Trends
2.5.1 C13 Stable Isotope Labeled Biomolecules Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by C13 Stable Isotope Labeled Biomolecules Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in C13 Stable Isotope Labeled Biomolecules as of 2022)
2.7 Date of Key Manufacturers Enter into C13 Stable Isotope Labeled Biomolecules Market
2.8 Key Manufacturers C13 Stable Isotope Labeled Biomolecules Product Offered
2.9 Mergers & Acquisitions, Expansion
3 C13 Stable Isotope Labeled Biomolecules Status and Outlook by Region
3.1 Global C13 Stable Isotope Labeled Biomolecules Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global C13 Stable Isotope Labeled Biomolecules Historic Market Size by Region
3.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales in Volume by Region (2018-2023)
3.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales in Value by Region (2018-2023)
3.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Region
3.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales in Volume by Region (2024-2029)
3.3.2 Global C13 Stable Isotope Labeled Biomolecules Sales in Value by Region (2024-2029)
3.3.3 Global C13 Stable Isotope Labeled Biomolecules Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global C13 Stable Isotope Labeled Biomolecules by Application
4.1 C13 Stable Isotope Labeled Biomolecules Market Segment by Application
4.1.1 Scientific Research
4.1.2 Medical
4.1.3 Industrial
4.1.4 Others
4.2 Global C13 Stable Isotope Labeled Biomolecules Market Size by Application
4.2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size Overview by Application (2018-2029)
4.2.2 Global C13 Stable Isotope Labeled Biomolecules Historic Market Size Review by Application (2018-2023)
4.2.3 Global C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Application (2018-2023)
4.3.2 Europe C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Application (2018-2023)
4.3.4 Latin America C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Breakdown by Application (2018-2023)
5 North America C13 Stable Isotope Labeled Biomolecules by Country
5.1 North America C13 Stable Isotope Labeled Biomolecules Historic Market Size by Country
5.1.1 North America C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2018-2023)
5.1.3 North America C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2018-2023)
5.2 North America C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Country
5.2.1 North America C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2024-2029)
5.2.2 North America C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2024-2029)
6 Europe C13 Stable Isotope Labeled Biomolecules by Country
6.1 Europe C13 Stable Isotope Labeled Biomolecules Historic Market Size by Country
6.1.1 Europe C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2018-2023)
6.1.3 Europe C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2018-2023)
6.2 Europe C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Country
6.2.1 Europe C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2024-2029)
6.2.2 Europe C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2024-2029)
7 Asia-Pacific C13 Stable Isotope Labeled Biomolecules by Region
7.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Historic Market Size by Region
7.1.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales in Value by Region (2018-2023)
7.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Region
7.2.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales in Value by Region (2024-2029)
8 Latin America C13 Stable Isotope Labeled Biomolecules by Country
8.1 Latin America C13 Stable Isotope Labeled Biomolecules Historic Market Size by Country
8.1.1 Latin America C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2018-2023)
8.1.3 Latin America C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2018-2023)
8.2 Latin America C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Country
8.2.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2024-2029)
8.2.2 Latin America C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2024-2029)
9 Middle East and Africa C13 Stable Isotope Labeled Biomolecules by Country
9.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Historic Market Size by Country
9.1.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2018-2023)
9.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Forecasted Market Size by Country
9.2.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Cambridge Isotope Laboratories
10.1.1 Cambridge Isotope Laboratories Company Information
10.1.2 Cambridge Isotope Laboratories Introduction and Business Overview
10.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Products Offered
10.1.5 Cambridge Isotope Laboratories Recent Development
10.2 Sigma-Aldrich
10.2.1 Sigma-Aldrich Company Information
10.2.2 Sigma-Aldrich Introduction and Business Overview
10.2.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Products Offered
10.2.5 Sigma-Aldrich Recent Development
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Company Information
10.3.2 Thermo Fisher Scientific Introduction and Business Overview
10.3.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Products Offered
10.3.5 Thermo Fisher Scientific Recent Development
10.4 LGC Standards
10.4.1 LGC Standards Company Information
10.4.2 LGC Standards Introduction and Business Overview
10.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Products Offered
10.4.5 LGC Standards Recent Development
10.5 Toronto Research Chemicals
10.5.1 Toronto Research Chemicals Company Information
10.5.2 Toronto Research Chemicals Introduction and Business Overview
10.5.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Products Offered
10.5.5 Toronto Research Chemicals Recent Development
10.6 IsoLife BV
10.6.1 IsoLife BV Company Information
10.6.2 IsoLife BV Introduction and Business Overview
10.6.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.6.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Products Offered
10.6.5 IsoLife BV Recent Development
10.7 WITEGA Laboratorien
10.7.1 WITEGA Laboratorien Company Information
10.7.2 WITEGA Laboratorien Introduction and Business Overview
10.7.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.7.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Products Offered
10.7.5 WITEGA Laboratorien Recent Development
10.8 Omicron Biochemicals
10.8.1 Omicron Biochemicals Company Information
10.8.2 Omicron Biochemicals Introduction and Business Overview
10.8.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Products Offered
10.8.5 Omicron Biochemicals Recent Development
10.9 Icon Isotopes
10.9.1 Icon Isotopes Company Information
10.9.2 Icon Isotopes Introduction and Business Overview
10.9.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Products Offered
10.9.5 Icon Isotopes Recent Development
10.10 Medical Isotopes
10.10.1 Medical Isotopes Company Information
10.10.2 Medical Isotopes Introduction and Business Overview
10.10.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Products Offered
10.10.5 Medical Isotopes Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 C13 Stable Isotope Labeled Biomolecules Industrial Chain Analysis
11.4 C13 Stable Isotope Labeled Biomolecules Market Dynamics
11.4.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
11.4.2 C13 Stable Isotope Labeled Biomolecules Market Drivers
11.4.3 C13 Stable Isotope Labeled Biomolecules Market Challenges
11.4.4 C13 Stable Isotope Labeled Biomolecules Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 C13 Stable Isotope Labeled Biomolecules Distributors
12.3 C13 Stable Isotope Labeled Biomolecules Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock